Abubacar, Men-ima D.
HRN: 22-45-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2023
CEFUROXIME 1.5GM (VIAL)
01/03/2023
01/10/2023
IV
1.5g
Q12
Fracture, For ORIF
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: No Wrong Dose Wrong Dose
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose